Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benshang Li

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|September 22, 2023
Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphomaXiaomin Yang, Chengjuan Luo, Juan Qian, et al.
International Journal of Cancer|April 26, 2025
GREM1 deficiency induced bone marrow adipose niche promotes B-cell acute lymphoblastic leukemia disease progressionLili Song, Rui Zhang, Liya Pan, et al.
Frontiers in Immunology|March 20, 2026
Emapalumab in pediatric patients with high-grade cytokine release syndrome associated with CAR T-cell therapyJing Zhang, Wenhua Shi, Jing Yang, et al.
Journal of Cancer Research and Clinical Oncology|March 12, 2017
Multivariate analysis of risk factors for patients with stage 4 neuroblastoma who were older than 18 months at diagnosis: a report from a single institute in Shanghai, ChinaJiaoyang Cai, Ci Pan, Yanjing Tang, et al.
Cell Transplantation|February 26, 2021
Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell TherapyTianyi Wang, Mingxuan Feng, Chengjuan Luo, et al.
Experimental and Molecular Pathology|August 9, 2021
Determination of COL1A1-PDGFB breakpoints by next-generation sequencing in the molecular diagnosis of dermatofibrosarcoma protuberansRuizheng Zhu, Jianna Yan, Benshang Li, et al.
Hematological Oncology|August 23, 2018
Long-term results of the risk-stratified treatment of childhood acute lymphoblastic leukemia in ChinaShuhong Shen, Jiaoyang Cai, Jing Chen, et al.
Blood|September 8, 2020
Identification of functional cooperative mutations of GNAO1 in human acute lymphoblastic leukemiaLili Song, Bo Yu, Yi Yang, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 28, 2021
Successful Treatment of TCF3-HLF-positive Childhood B-ALL with Chimeric Antigen Receptor T-Cell TherapyTianyi Wang, Xinyu Wan, Fan Yang, et al.
Cancer Research and Treatment|September 29, 2021
Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary RelapseXinyu Wan, Xiaomin Yang, Fan Yang, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|September 22, 2023
Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphomaXiaomin Yang, Chengjuan Luo, Juan Qian, et al.
International Journal of Cancer|April 26, 2025
GREM1 deficiency induced bone marrow adipose niche promotes B-cell acute lymphoblastic leukemia disease progressionLili Song, Rui Zhang, Liya Pan, et al.
Frontiers in Immunology|March 20, 2026
Emapalumab in pediatric patients with high-grade cytokine release syndrome associated with CAR T-cell therapyJing Zhang, Wenhua Shi, Jing Yang, et al.
Journal of Cancer Research and Clinical Oncology|March 12, 2017
Multivariate analysis of risk factors for patients with stage 4 neuroblastoma who were older than 18 months at diagnosis: a report from a single institute in Shanghai, ChinaJiaoyang Cai, Ci Pan, Yanjing Tang, et al.
Cell Transplantation|February 26, 2021
Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell TherapyTianyi Wang, Mingxuan Feng, Chengjuan Luo, et al.
Experimental and Molecular Pathology|August 9, 2021
Determination of COL1A1-PDGFB breakpoints by next-generation sequencing in the molecular diagnosis of dermatofibrosarcoma protuberansRuizheng Zhu, Jianna Yan, Benshang Li, et al.
Hematological Oncology|August 23, 2018
Long-term results of the risk-stratified treatment of childhood acute lymphoblastic leukemia in ChinaShuhong Shen, Jiaoyang Cai, Jing Chen, et al.
Blood|September 8, 2020
Identification of functional cooperative mutations of GNAO1 in human acute lymphoblastic leukemiaLili Song, Bo Yu, Yi Yang, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 28, 2021
Successful Treatment of TCF3-HLF-positive Childhood B-ALL with Chimeric Antigen Receptor T-Cell TherapyTianyi Wang, Xinyu Wan, Fan Yang, et al.
Cancer Research and Treatment|September 29, 2021
Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary RelapseXinyu Wan, Xiaomin Yang, Fan Yang, et al.
Pageof 5